Literature DB >> 2840263

Effects of transforming growth factor-beta on deoxyribonucleic acid synthesis and iodine metabolism in porcine thyroid cells in culture.

T Tsushima1, M Arai, M Saji, Y Ohba, H Murakami, E Ohmura, K Sato, K Shizume.   

Abstract

The effect of transforming growth factor (TGF)-beta on DNA synthesis and iodine metabolism was studied in cultured porcine thyroid cells. TGF-beta dose-dependently inhibited DNA synthesis stimulated by both insulin-like growth factor I and epidermal growth factor but did not affect the number or affinity of receptors for the two growth factors, suggesting that TGF-beta inhibits postreceptor events responsible for initiation of DNA synthesis. TGF-beta was a potent inhibitor of iodine metabolism. When porcine thyroid cells were cultured with TSH for 3 days in the presence of TGF-beta, TSH-induced iodide uptake and organification were reduced at rates that were dependent on the TGF-beta concentrations. The inhibition was detectable at TGF-beta concentrations as low as 50 pg/ml, and complete suppression was seen at 1 ng/ml. Only 6 h of exposure to TGF-beta resulted in a significant inhibition of TSH-induced iodine metabolism. Treatment of thyroid cells with TGF-beta for 3 days did not reduce cAMP production stimulated by TSH. Moreover, the intracellular cAMP level of thyroid cells cultured with TSH plus TGF-beta did not differ from that of cells cultured with TSH alone. TGF-beta decreased iodide uptake stimulated by forskolin or 8-bromo-cAMP. These results strongly suggest that TGF-beta inhibits TSH-stimulated iodine metabolism, at least in part, by affecting events subsequent to cAMP production. The physiological role of TGF-beta remains to be determined, but it may be involved in the regulation of thyroid cell growth and function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840263     DOI: 10.1210/endo-123-2-1187

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  NADPH Oxidase NOX4 Is a Critical Mediator of BRAFV600E-Induced Downregulation of the Sodium/Iodide Symporter in Papillary Thyroid Carcinomas.

Authors:  Naïma Azouzi; Jérémy Cailloux; Juliana M Cazarin; Jeffrey A Knauf; Jennifer Cracchiolo; Abir Al Ghuzlan; Dana Hartl; Michel Polak; Aurore Carré; Mohammed El Mzibri; Abdelkarim Filali-Maltouf; Abderrahmane Al Bouzidi; Martin Schlumberger; James A Fagin; Rabii Ameziane-El-Hassani; Corinne Dupuy
Journal:  Antioxid Redox Signal       Date:  2016-08-22       Impact factor: 8.401

2.  TGF beta 1 immunostaining patterns and locations in adenoma which later recurred.

Authors:  P P Morosini; A Taccaliti; R Montironi; L Diamanti; M Scarpelli; G Simonella; V Mancini; M D Petrelli; G Fabris; F Mantero
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

3.  Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).

Authors:  F Depoortere; I Pirson; J Bartek; J E Dumont; P P Roger
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

4.  Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-beta pathway.

Authors:  Arianna Nicolussi; Sonia D'Inzeo; Angela Gismondi; Anna Coppa
Journal:  Clin Exp Metastasis       Date:  2006-11-03       Impact factor: 5.150

5.  Influence of signal transducer and activator of transcription-1 signaling on thyroid morphology and function.

Authors:  Hiroaki J Kimura; Roberto Rocchi; Melissa A Landek-Salgado; Koichi Suzuki; Cindy Y Chen; Miho Kimura; Noel R Rose; Patrizio Caturegli
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

6.  Analysis of TGF-B and TGF-B-RII in Thyroid Neoplasms from the United States, Japan, and China.

Authors:  Yoshiaki Imamura; Long Jin; Joseph P. Grande; Chin-Yang Li; T-R. Zheng; Lori A. Erickson; Ricardo V. Lloyd
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

7.  Transforming growth factor-beta 1 is more expressed in thyroid follicular adenoma than in normal tissue.

Authors:  P Morosini; A Taccaliti; C Di Loreto; G Arnaldi; E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

8.  Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.

Authors:  J A Knauf; M A Sartor; M Medvedovic; E Lundsmith; M Ryder; M Salzano; Y E Nikiforov; T J Giordano; R A Ghossein; J A Fagin
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.